ArticleCancer discovery2026

First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

S Daniel Haldar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.